Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
4.560
-0.010 (-0.22%)
Jun 8, 2026, 10:30 AM EDT - Market open
Myriad Genetics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $8.5 | Buy | Maintains | $8.5 | +86.40% | May 12, 2026 |
| Bank of America Securities | Bank of America Securities | Sell Maintains n/a | Sell | Maintains | n/a | n/a | May 7, 2026 |
Unknown Analyst Guggenheim No rating | Guggenheim | Hold Maintains n/a | Hold | Maintains | n/a | n/a | May 7, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $6 → $5.5 | Hold | Maintains | $6 → $5.5 | +20.61% | May 6, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Reiterates $10 | Buy | Reiterates | $10 | +119.30% | May 6, 2026 |
| TD Cowen | TD Cowen | Hold Maintains $7 → $6 | Hold | Maintains | $7 → $6 | +31.58% | May 6, 2026 |
| UBS | UBS | Hold Maintains $8 → $6 | Hold | Maintains | $8 → $6 | +31.58% | Feb 24, 2026 |
| Raymond James | Raymond James | Buy Maintains $6.53 → $8 | Buy | Maintains | $6.53 → $8 | +75.44% | Jan 13, 2026 |